Tissue transglutaminase clusters soluble A-type ephrins into functionally active high molecular weight oligomers

Experimental Cell Research

Volumn 313, Issue 20, 2007, Pages 4170-4179

  Alford, Spencer C ^a   Bazowski, Jessa ^a   Lorimer, Heather ^a   Elowe, Sabine ^b   Howard, Perry L ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Clustering; Eph; Ephrin; Oligomerization; Transglutaminase

Indexed keywords

EPHRIN RECEPTOR A1; EPHRIN RECEPTOR A5; OLIGOMER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CONTACT; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 36048971979     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.07.019     Document Type: Article

References (31)

1. Gale N.W., Holland S.J., Valenzuela D.M., Flenniken A., Pan L., Ryan T.E., Henkemeyer M., Strebhardt K., Hirai H., Wilkinson D.G., Pawson T., Davis S., and Yancopoulos G.D. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 17 (1996) 9-19
2. Himanen J.P., Chumley M.J., Lackmann M., Li C., Barton W.A., Jeffrey P.D., Vearing C., Geleick D., Feldheim D.A., Boyd A.W., Henkemeyer M., and Nikolov D.B. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat. Neurosci. 7 (2004) 501-509
3. Depaepe V., Suarez-Gonzalez N., Dufour A., Passante L., Gorski J.A., Jones K.R., Ledent C., and Vanderhaeghen P. Ephrin signalling controls brain size by regulating apoptosis of neural progenitors. Nature 435 (2005) 1244-1250
4. Vearing C.J., and Lackmann M. Eph receptor signalling; dimerisation just isn't enough. Growth Factors 23 (2005) 67-76
5. Konstantinova I., Nikolova G., Ohara-Imaizumi M., Meda P., Kucera T., Zarbalis K., Wurst W., Nagamatsu S., and Lammert E. EphA-ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets. Cell 129 (2007) 359-370
6. Klein R. Eph/ephrin signaling in morphogenesis, neural development and plasticity. Curr. Opin. Cell Biol. 16 (2004) 580-589
7. Cowan C.A., and Henkemeyer M. Ephrins in reverse, park and drive. Trends Cell Biol. 12 (2002) 339-346
8. Davis S., Gale N.W., Aldrich T.H., Maisonpierre P.C., Lhotak V., Pawson T., Goldfarb M., and Yancopoulos G.D. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266 (1994) 816-819
9. Holland S.J., Gale N.W., Mbamalu G., Yancopoulos G.D., Henkemeyer M., and Pawson T. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 383 (1996) 722-725
10. Bruckner K., Pasquale E.B., and Klein R. Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science 275 (1997) 1640-1643
11. Henkemeyer M., Orioli D., Henderson J., Saxton T., Roder T.M., Pawson J., and Klein T. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 86 (1996) 35-46
12. Hattori M., Osterfield M., and Flanagan J.G. Regulated cleavage of a contact-mediated axon repellent. Science 289 (2000) 1360-1365
13. Aasheim H.C., Munthe E., Funderud S., Smeland E.B., Beiske K., and Logtenberg T. A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes. Blood 95 (2000) 221-230
14. Dixit V.M., Green S., Sarma V., Holzman L.B., Wolf F.W., O'Rourke K., Ward P.A., Prochownik E.V., and Marks R.M. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J. Biol. Chem. 265 (1990) 2973-2978
15. Pandey A., Shao H., Marks R.M., Polverini P.J., and Dixit V.M. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science 268 (1995)
16. Bartley T.D., Hunt R.W., Welcher A.A., Boyle W.J., Parker V.P., Lindberg R.A., Lu H.S., Colombero A.M., Elliott R.L., and Guthrie B.A. B61 is a ligand for the ECK receptor protein-tyrosine kinase. Nature 368 (1994) 558-560
17. Winslow J.W., Moran P., Valverde J., Shih A., Yuan J.Q., Wong S.C., Tsai S.P., Goddard A., Henzel W.J., and Hefti F. Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation. Neuron 14 (1995) 973-981
18. Mangala L.S., and Mehta K. Tissue transglutaminase (TG2) in cancer biology. Prog. Exp. Tumor Res. 38 (2005) 125-138
19. Iismaa S.E., Chung L., Wu M.J., Teller D.C., Yee V.C., and Graham R.M. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP. Biochemistry 36 (1997) 11655-11664
20. Mishra S., and Murphy L.J. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J. Biol. Chem. 279 (2004) 23863-23868
21. Bruckner K., Pablo L.J., Scheiffele P., Herb A., Seeburg P.H., and Klein R. EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron 22 (1999) 511-524
22. Gauthier L.R., and Robbins S.M. Ephrin signaling: one raft to rule them all? One raft to sort them? One raft to spread their call and in signaling bind them?. Life Sci. 74 (2003) 207-216
23. Stein E., Lane A.A., Cerretti D.P., Schoecklmann H.O., Schroff A.D., Van Etten R.L., and Daniel T.O. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 12 (1998) 667-678
24. Himanen J.P., Rajashankar K.R., Lackmann M., Cowan C.A., Henkemeyer M., and Nikolov D.B. Crystal structure of an Eph receptor-ephrin complex. Nature 414 (2001) 933-938
25. Mehta K., Fok J.Y., and Mangala L.S. Tissue transglutaminase: from biological glue to cell survival cues. Front. Biosci. 11 (2006) 173-185
26. Mangala L.S., Arun B., Sahin A.A., and Mehta K. Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion. Mol. Cancer 4 (2005) 33
27. Chen J.S., and Mehta K. Tissue transglutaminase: an enzyme with a split personality. Int. J. Biochem. Cell Biol. 31 (1999) 817-836
28. Akimov S.S., and Belkin A.M. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFβ-dependent matrix deposition. J. Cell Sci. 114 (2001) 2989-3000
29. Munger J.S., Harpel J.G., Gleizes P.E., Mazzieri R., Nunes I., and Rifkin D.B. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int. 51 (1997) 1376-1382
30. Sakai K., Busby Jr. W.H., Clarke J.B., and Clemmons D.R. Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis. J. Biol. Chem. 276 (2001) 8740-8745
31. Nunes I., Gleizes P.E., Metz C.N., and Rifkin D.B. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J. Cell Biol. 136 (1997) 1151-1163